ArticleTrials2019

Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.

Jing Gan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.